• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Prevalence of hEDS in POTS/ march 2020/ USA

pattismith

Senior Member
Messages
3,945
Abstract
Despite well-established clinical associations between Hypermobile Ehlers-Danlos syndrome (hEDS) and postural orthostatic tachycardia syndrome (POTS), the precise prevalence is unknown.

We therefore evaluated for hEDS in 91 POTS participants using the 2017 hEDS diagnostic checklist, which has three major criteria: 1) generalized joint hypermobility (Beighton score), 2) systemic features, family history, and 3) absence of exclusion criteria.

Overall, 28 out of 91 POTS participants (31%) met clinical criteria for hEDS.

An additional 24% of participants had generalized joint hypermobility without meeting hEDS criteria.

Identifying the prevalence of hEDS in POTS is important for understanding possible mechanisms connecting these two syndromes.